LeonaBio Inc
LONA
92 hedge funds and large institutions have $234M invested in LeonaBio Inc in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 15 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 23
33% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 15
5% more funds holding
Funds holding: 88 → 92 (+4)
0.03% more ownership
Funds ownership: 6.65% → 6.68% (+0.03%)
8% less capital invested
Capital invested by funds: $253M → $234M (-$19.5M)
43% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $3.62M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$4.94M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.53M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.79M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$6.95M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.56M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.32M |
| 4 |
VA
VR Adviser
New York
|
-$2.94M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.04M |
LONA Hedge Fund Activity: Q3 2021 in Review
92 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q3 2021, worth a combined $234M — down 7.7% from $253M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LONA positions and 15 closed out — a net gain of 5 holders — while 31 added to existing stakes and 23 trimmed.
The largest buyer was Pathstone Family Office, adding an estimated $4.94M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $6.95M sold.
- 92 institutional investors held LeonaBio Inc (LONA) as of Q3 2021, up from 88 in Q2 2021.
- Funds reported $234M of LeonaBio Inc stock for Q3 2021, down 7.7% quarter-over-quarter.
- 20 funds opened new LeonaBio Inc positions in Q3 2021 and 15 closed out, a net change of +5 holders.
- The largest LeonaBio Inc buyer in Q3 2021 was Pathstone Family Office, an estimated $4.94M added.
- The largest LeonaBio Inc seller in Q3 2021 was PFM Health Sciences, an estimated $6.95M sold.
Based on aggregated 13F filings for Q3 2021.